Control line derived from the parental XCL-1, an integration-free iPSC line
Aplicación
These products provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer′s disease (AD), Parkinson′s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), as well as for drug screening and toxicology applications in the neural space.
Características y beneficios
This product contains cryo-preserved, pre-differentiated mixed population neurons derived from a footprint-free, karyotype normal human iPSC line. It was designed for customers to generate mature neurons using the optimized maturation medium and supplement (NEUR1050, NEUR1051 sold separately). Mature neurons can be obtained within 8 days. The neurons can be seeded on various culture vessel formats including 96 well plates on either glass or plastic surfaces and cultured as adherent cells. Shortly after seeding, the cells proliferate slightly for up to 3 days and show extensive neurite outgrowth and proper neuronal morphology. In general, at 8 days post-seeding, the cell population will contain ≥98% neurons and ≤1% Glial Fibrillary Acidic Protein (GFAP) positive astrocytes.
Medio de cultivo
User must also purchase Neuronal Maturation Medium, NEUR1050 (50mL) or NEUR1051 (250mL). Sold separately.
Rutina de subcultivo
No subculture routine is necessary. See technical bulletin for additional details.
Código de clase de almacenamiento
10 - Combustible liquids
Clase de riesgo para el agua (WGK)
WGK 3
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Elija entre una de las versiones más recientes:
Certificados de análisis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.
Journal of biomolecular screening, 19(1), 32-43 (2013-09-11)
Rapid and effective drug discovery for neurodegenerative disease is currently impeded by an inability to source primary neural cells for high-throughput and phenotypic screens. This limitation can be addressed through the use of pluripotent stem cells (PSCs), which can be
Human pluripotent stem cells (hPSCs), including human embryonic stem cells and human induced pluripotent stem cells, are unique cell sources for disease modeling, drug discovery screens, and cell therapy applications. The first step in producing neural lineages from hPSCs is
Questions
Reviews
★★★★★ No rating value
Active Filters
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.